Literature DB >> 30834653

Development of alopecia in patients treated with dupilumab.

Nolan J Maloney1, Scott Worswick2, Kyle Cheng1.   

Abstract

Entities:  

Year:  2019        PMID： 30834653     DOI： 10.1111/dth.12869

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  6 in total

1.  Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.

Authors:  Maurizio Romagnuolo; Mauro Barbareschi; Simona Tavecchio; Luisa Angileri; Silvia Mariel Ferrucci
Journal:  Skin Appendage Disord       Date:  2021-07-27

2.  Massive Acute Alopecia of the Scalp in a Patient Treated with Dupilumab.

Authors:  Rosella Gallo; Ilaria Trave; Aurora Parodi
Journal:  Acta Derm Venereol       Date:  2020-06-18       Impact factor: 3.875

3.  Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.

Authors:  Shintaro Takeoka; Masahiro Kamata; Ikumi Yokoi; Aya Takehara; Yayoi Tada
Journal:  Acta Derm Venereol       Date:  2021-10-28       Impact factor: 3.875

Review 4.  Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Authors:  Reinhart Speeckaert; Jo Lambert; Nanja van Geel
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

5.  IL-4Rα expression by airway epithelium and smooth muscle accounts for nearly all airway hyperresponsiveness in murine allergic airway disease.

Authors:  Christopher G McKnight; Crystal Potter; Fred D Finkelman
Journal:  Mucosal Immunol       Date:  2019-11-19       Impact factor: 7.313

Review 6.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.